May 23, 2005

12 Min Read
Women's Health References

May 23, 2005 - Natural Products Industry INSIDER
"Women's Health" References

1. Shamberger RJ. "Calcium, magnesium, and other elements in the redblood cells and hair of normals and patients with premenstrual syndrome." BiolTrace Elem Res. 94, 2:123-9, 2003.

2. Bendich A. "Micronutrients in women's health and immunefunction." Nutrition. 17, 10:858-67, 2001.

3. Fugh-Berman A, Kronenberg F. "Complementary and alternative medicine(CAM) in reproductive-age women: a review of randomized controlled trials."Reprod Toxicol. 17, 2:137-52, 2003.

4. De Souza MC et al. "A synergistic effect of a daily supplement for 1month of 200 mg magnesium plus 50 mg vitamin B6 for the relief ofanxiety-related premenstrual symptoms: a randomized, double-blind, crossoverstudy." J Womens Health Gend Based Med. 9, 2:131-9, 2000.

5. Ziaei S, Zakeri M, Kazemnejad A. "A randomized controlled trial ofvitamin E in the treatment of primary dysmenorrhoea." BJOG. 112,4:466-9, 2005.

6. Ziaei S et al. "A randomized placebo-controlled trial to determinethe effect of vitamin E in treatment of primary dysmenorrhoea." BJOG.108, 11:1181-3, 2001.

7. Wuttke W et al. "Chaste tree (Vitex agnus-castus)--pharmacology andclinical indications." Phytomedicine. 10, 4:348-57, 2003.

8. Loch EG, Selle H, Boblitz N. "Treatment of premenstrual syndrome witha phytopharmaceutical formulation containing Vitex agnus castus." JWomens Health Gend Based Med. 9, 3:315-20, 2000.

9. Atmaca M, Kumru S, Tezcan E. "Fluoxetine versus Vitex agnus castusextract in the treatment of premenstrual dysphoric disorder." HumPsychopharmacol. 18, 3:191-5, 2003.

10. Kohama T et al. "Analgesic efficacy of French maritime pine barkextract in dysmenorrhea: an open clinical trial." J Reprod Med. 49,10:828-32, 2004.

11. Rossouw JE et al. "Risks and benefits of estrogen plus progestin inhealthy postmenopausal women: principal results from the Women's HealthInitiative randomized controlled trial." JAMA. 288, 3:321-33, 2002.

12. Kelly JP et al. "Use of postmenopausal hormone therapy since theWomen's Health Initiative findings." Pharmacoepidemiol Drug Saf.April 5, 2005 [Epub ahead of print].

13. Mahady GB et al. "Botanical dietary supplement use in peri- andpostmenopausal women." Menopause. 10, 1:65-72, 2003.

14. North American Menopause Society. "Treatment of menopause-associatedvasomotor symptoms: position statement of The North American MenopauseSociety." Menopause. 11, 1:11-33, 2004.

15. Kronenberg F, Fugh-Berman A. "Complementary and alternative medicinefor menopausal symptoms: a review of randomized, controlled trials." AnnIntern Med. 137, 10:805-13, 2002.

16. Krebs EE et al. "Phytoestrogens for treatment of menopausalsymptoms: a systematic review." Obstet Gynecol. 104, 4:824-36,

17. Petri Nahas E et al. "Benefits of soy germ isoflavones inpostmenopausal women with contraindication for conventional hormone replacementtherapy." Maturitas. 48, 4:372-80, 2004.

18. Colacurci N et al. "Effects of soy isoflavones on menopausalneurovegetative symptoms." Minerva Ginecol. 56, 5:407-12, 2004.

19. Rosell MS et al. "Soy intake and blood cholesterol concentrations: across-sectional study of 1033 pre- and postmenopausal women in the Oxford arm ofthe European Prospective Investigation into Cancer and Nutrition." Am JClin Nutr. 80, 5:1391-6, 2004.

20. Zhan S, Ho SC. "Meta-analysis of the effects of soy proteincontaining isoflavones on the lipid profile." Am J Clin Nutr. 81,2:397-408, 2005.

21. Engelman HM et al. "Blood lipid and oxidative stress responses tosoy protein with isoflavones and phytic acid in postmenopausal women." AmJ Clin Nutr. 81, 3:590-6, 2005.

22. Blum A et al. "Effects of soy protein on endothelium-dependentvasodilatation and lipid profile in postmenopausal women with mildhypercholesterolemia." Clin Invest Med. 26, 1:20-6, 2003.

23. Kreijkamp-Kaspers S et al. "Randomized controlled trial of theeffects of soy protein containing isoflavones on vascular function inpostmenopausal women." Am J Clin Nutr. 81, 1:189-95, 2005.

24. Steinberg FM et al. "Soy protein with isoflavones has favorableeffects on endothelial function that are independent of lipid and antioxidanteffects in healthy postmenopausal women." Am J Clin Nutr. 78,1:123-30, 2003.

25. Cuevas AM et al. "Isolated soy protein improves endothelial functionin postmenopausal hypercholesterolemic women." Eur J Clin Nutr. 57,8:889-94, 2003.

26. Upmalis DH et al. "Vasomotor symptom relief by soy isoflavoneextract tablets in postmenopausal women: a multicenter, double-blind,randomized, placebo-controlled study." Menopause. 7, 4:236-42,

27. Scambia G et al. "Clinical effects of a standardized soy extract inpostmenopausal women: a pilot study." Menopause. 7, 2:105-11, 2000.

28. Setchell KD et al. "Pharmacokinetics of a slow-release formulationof soybean isoflavones in healthy postmenopausal women." J Agric FoodChem. 53, 6:1938-44, 2005.

29. Kliger B. "Black cohosh." Am Fam Physician. 68:114-6,

30. Huntley A. "The safety of black cohosh (Actaea racemosa,Cimicifuga racemosa)." Expert Opin Drug Saf. 3, 6:615-23, 2004.

31. Pockaj BA et al. "Pilot evaluation of black cohosh for the treatmentof hot flashes in women." Cancer Invest. 22, 4:515-21, 2004.

32. Wuttke W, Seidlova-Wuttke D, Gorkow C. "The Cimicifuga preparationBNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study:effects on menopause symptoms and bone markers." Maturitas. 44 Suppl1:S67-77, 2003.

33. Lupu R et al. "Black cohosh, a menopausal remedy, does not haveestrogenic activity and does not promote breast cancer cell growth." IntJ Oncol. 23, 5:1407-12, 2003.

34. Bodinet C, Freudenstein J. "Influence of marketed herbal menopausepreparations on MCF-7 cell proliferation." Menopause. 11, 3:281-9,2004.

35. Tice JA et al. "Phytoestrogen supplements for the treatment of hotflashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlledtrial." JAMA. 290, 2:207-14, 2003.

36. van de Weijer PH, Barentsen R. "Isoflavones from red clover(Promensil) significantly reduce menopausal hot flush symptoms compared withplacebo." Maturitas. 42, 3:187-93, 2002.

37. Kupfersztain C et al. "The immediate effect of natural plantextract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatmentof hot flushes during menopause. A preliminary report." Clin Exp ObstetGynecol. 30, 4:203-6, 2003.

38. Bagchi D et al. "Phytoestrogen, resveratrol and women'shealth." Res Commun Pharmacol Toxicol. 5, 1-2:107-21, 2000.

39. Bagchi D et al. "Benefits of resveratrol in women's health." DrugsExp Clin Res. 27, 5-6:233-48, 2001.

40. Mokbel K. "Risk-reducing strategies for breast cancer--a review ofrecent literature." Int J Fertil Womens Med. 48, 6:274-7, 2003.

41. Fleischauer AT, Simonsen N, Arab L. "Antioxidant supplements andrisk of breast cancer recurrence and breast cancer-related mortality amongpostmenopausal women." Nutr Cancer. 46, 1:15-22, 2003.

42. Branda RF et al. "Effect of vitamin B12, folate, and dietarysupplements on breast carcinoma chemotherapy--induced mucositis andneutropenia." Cancer. 101, 5:1058-64, 2004.

43. Sylvester PW, Shah SJ. "Mechanisms mediating the antiproliferativeand apoptotic effects of vitamin E in mammary cancer cells." FrontBiosci. 10:699-709, 2005.

44. Zhang SM. "Role of vitamins in the risk, prevention, and treatmentof breast cancer." Curr Opin Obstet Gynecol. 16, 1:19-25, 2004.

45. Zhang SM et al. "Plasma folate, vitamin B6, vitamin B12,homocysteine, and risk of breast cancer." J Natl Cancer Inst. 95,5:373-80, 2003.

46. Shrubsole MJ et al. "Dietary folate intake and breast cancer risk:results from the Shanghai Breast Cancer Study." Cancer Res. 61,19:7136-41, 2001.

47. Tamimi RM et al. "Plasma carotenoids, retinol, and tocopherols andrisk of breast cancer." Am J Epidemiol. 161, 2:153-60, 2005.

48. Sato R et al. "Prospective study of carotenoids, tocopherols, andretinoid concentrations and the risk of breast cancer." Cancer EpidemiolBiomarkers Prev. 11, 5:451-7, 2002.

49. Bosetti C et al. "Flavonoids and breast cancer risk in Italy." CancerEpidemiol Biomarkers Prev. 14, 4:805-8, 2005.

50. Peterson J et al. "Flavonoid intake and breast cancer risk: acase--control study in Greece." Br J Cancer. 89, 7:1255-9, 2003.

51. Kim H et al. "Chemoprevention by grape seed extract and genistein incarcinogen-induced mammary cancer in rats is diet dependent." J Nutr.134, 12 Suppl:3445S-3452S, 2004.

52. Eng ET et al. "Suppression of estrogen biosynthesis by procyanidindimers in red wine and grape seeds." Cancer Res. 63, 23:8516-22,2003.

53. Banerjee S, Bueso-Ramos C, Aggarwal BB. "Suppression of7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats byresveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrixmetalloprotease 9." Cancer Res. 62, 17:4945-54, 2002.

54. Wu AH et al. "Green tea and risk of breast cancer in AsianAmericans." Int J Cancer. 106, 4:574-9, 2003.

55. Yuan JM et al. "Green tea intake, ACE gene polymorphism and breastcancer risk among Chinese women in Singapore." Carcinogenesis. March31, 2005 [Epub ahead of print].

56. Vergote D et al. "(-)-Epigallocatechin (EGC) of green tea inducesapoptosis of human breast cancer cells but not of their normalcounterparts." Breast Cancer Res Treat. 76, 3:195-201, 2002.

57. Zhou JR et al. "Combined inhibition of estrogen-dependent humanbreast carcinoma by soy and tea bioactive components in mice." Int JCancer. 108, 1:8-14, 2004.

58. Yan L, Spitznagel E. "A meta-analysis of soyfoods and risk of breastcancer in women." Int J Cancer Prev. 1, 4:281-93, 2005.

59. Badger TM et al. "Soy protein isolate and protection againstcancer." J Am Coll Nutr. 24, 2:146S-149S, 2005.

60. McCann SE et al. "Dietary lignan intakes and risk of pre- andpostmenopausal breast cancer." Int J Cancer. 111, 3:440-3, 2004.

61. Haggans CJ et al. "The effect of flaxseed and wheat bran consumptionon urinary estrogen metabolites in premenopausal women." CancerEpidemiol Biomarkers Prev. 9:719-25, 2000.

62. Thompson LU et al. "Biological effects of dietary flaxseed inpatients with breast cancer." Breast Cancer Res Treat. 64:50, 2000.

63. Chen J, Thompson LU. "Lignans and tamoxifen, alone or incombination, reduce human breast cancer cell adhesion, invasion and migration invitro." Breast Cancer Res Treat. 80, 2:163-70, 2003.

64. Kemp MQ, Jeffy BD, Romagnolo DF. "Conjugated linoleic acid inhibitscell proliferation through a p53-dependent mechanism: effects on the expressionof G1-restriction points in breast and colon cancer cells." J Nutr.133, 11:3670-7, 2003.

65. Masso-Welch PA et al. "Isomers of conjugated linoleic acid differ intheir effects on angiogenesis and survival of mouse mammary adiposevasculature." J Nutr. 134, 2:299-307, 2004.

66. Lavillonniere F et al. "Dietary purified cis-9,trans-11 conjugatedlinoleic acid isomer has anticarcinogenic properties in chemically inducedmammary tumors in rats." Nutr Cancer. 45, 2:190-4, 2003.

67. Hubbard NE, Lim D, Erickson KL. "Effect of separate conjugatedlinoleic acid isomers on murine mammary tumorigenesis." Cancer Lett.190, 1:13-9, 2003.

68. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate(IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion,migration and invasion of MDA-MB 231 human breast cancer cells." AnticancerRes. 23, 5A:3671-9, 2003.

69. Tantivejkul K, Vucenik I, Shamsuddin AM. "Inositol hexaphosphate(IP6) inhibits key events of cancer metastasis: II. Effects on integrins andfocal adhesions." Anticancer Res. 23, 5A:3681-9, 2003.

70. Tantivejkul K et al. "Inositol hexaphosphate (IP6) enhances theanti-proliferative effects of adriamycin and tamoxifen in breast cancer." BreastCancer Res Treat. 79, 3:301-12, 2003.

71. Coxam V. "[New advances in osteoporosis nutritionalprevention.]" Med Sci (Paris). 21, 3:297-301, 2005.

72. Deplas A et al. "Bone density, parathyroid hormone, calcium andvitamin D nutritional status of institutionalized elderly subjects." JNutr Health Aging. 8, 5:400-4, 2004.

73. Holick MF et al. "Prevalence of vitamin D inadequacy amongpostmenopausal North American women receiving osteoporosis therapy." JClin Endocrinol Metab. March 29, 2005 [Epub ahead of print].

74. Malabanan AO, Holick MF. "Vitamin D and bone health inpostmenopausal women." J Womens Health (Larchmt). 12, 2:151-6,

75. Di Daniele N et al. "Effect of supplementation of calcium andvitamin D on bone mineral density and bone mineral content in peri- andpost-menopause women; a double-blind, randomized, controlled trial." PharmacolRes. 50, 6:637-41, 2004.

76. Nieves JW. "Calcium, vitamin D, and nutrition in elderlyadults." Clin Geriatr Med. 19, 2:321-35, 2003.

77. Heaney RP, Rafferty K, Dowell MS. "Effect of yogurt on a urinarymarker of bone resorption in postmenopausal women." J Am Diet Assoc.102, 11:1672-4, 2002.

78. Narva M et al. "The effect of Lactobacillus helveticus fermentedmilk on acute changes in calcium metabolism in postmenopausal women." EurJ Nutr. 43, 2:61-8, 2004.

79. Rao LG, Khan T. "TK." 31st European Symposium on CalcifiedTissues, Nice, France, June 5-9, 2004.

80. Tucker KL. "Dietary intake and bone status with aging." CurrPharm Des. 9, 32:2687-704, 2003.

81. Maurer J et al. "Dietary iron positively influences bone mineraldensity in postmenopausal women on hormone replacement therapy." J Nutr.135, 4:863-9, 2005.

82. Harris MM et al. "Dietary iron is associated with bone mineraldensity in healthy postmenopausal women." J Nutr. 133, 11:3598-602,2003.

83. Arjmandi BH et al. "Soy protein has a greater effect on bone inpostmenopausal women not on hormone replacement therapy, as evidenced byreducing bone resorption and urinary calcium excretion." J ClinEndocrinol Metab. 88, 3:1048-54, 2003.

84. Ho SC et al. "Soy protein consumption and bone mass in earlypostmenopausal Chinese women." Osteoporos Int. 14, 10:835-42, 2003.

85. Lydeking-Olsen E et al. "Soymilk or progesterone for prevention ofbone loss--a 2 year randomized, placebo-controlled trial." Eur J Nutr.43, 4:246-57, 2004.

86. Kreijkamp-Kaspers S et al. "Effect of soy protein containingisoflavones on cognitive function, bone mineral density, and plasma lipids inpostmenopausal women: a randomized controlled trial." JAMA. 292,1:65-74, 2004.

87. Harkness LS et al. "Decreased bone resorption with soy isoflavonesupplementation in postmenopausal women." J Womens Health (Larchmt).13, 9:1000-7, 2004.

88. Chen YM et al. "Beneficial effect of soy isoflavones on bone mineralcontent was modified by years since menopause, body weight, and calcium intake:a double-blind, randomized, controlled trial." Menopause. 11,3:246-54, 2004.

89. Mathey JP et al. "Fructooligosaccharides maximize bone-sparingeffects of soy isoflavone-enriched diet in the ovarietomized rat." CalcifTissue Int. 75, 2:169-79, 2004.

90. Ohta A et al. "A combination of dietary fructooligosaccharides andisoflavone conjugates increases femoral bone mineral density and equolproduction in ovariectomized mice." J Nutr. 132, 7:2049-54, 2002.

91. Katsuyama H et al. "Promotion of bone formation by fermented soybean(Natto) intake in premenopausal women." J Nutr Sci Vitaminol (Tokyo).50, 2:114-20, 2004.

92. Katsuyama H et al. "Usual dietary intake of fermented soybeans(Natto) is associated with bone mineral density in premenopausal women." JNutr Sci Vitaminol (Tokyo). 48, 3:207-15, 2002.

93. SOGC. "The detection and management of vaginal atrophy." IntJ Gynaecol Obstet. 88, 2:222-8, 2005.

94. Jepson RG, Mihaljevic L, Craig J. "Cranberries for preventingurinary tract infections." Cochrane Database Syst Rev. 2:CD001321,2004.

95. Raz R, Chazan B, Dan M. "[Cranberry juice and urinary tractinfection.]" Harefuah. 143, 12:891-4, 909, 2004.

96. Kontiokari T et al. "Randomized trial of cranberry-lingonberry juiceand Lactobacillus GG drink for the prevention of urinary tract infections inwomen." BMJ. 322, 7302:1571, 2001.

97. Stothers L. "A randomized trial to evaluate effectiveness and costeffectiveness of naturopathic cranberry products as prophylaxis against urinarytract infection in women." Can J Urol. 9, 3:1558-62, 2002.

98. Reid G, Burton J, Devillard E. "The rationale for probiotics infemale urogenital healthcare." MedGenMed. 6, 1:49, 2004.

99. Reid G et al. "Nucleic acid-based diagnosis of bacterial vaginosisand improved management using probiotic lactobacilli." J Med Food.7, 2:223-8, 2004.

100. Reid G et al. "Oral use of Lactobacillus rhamnosus GR-1 and L.fermentum RC-14 significantly alters vaginal flora: randomized,placebo-controlled trial in 64 healthy women." FEMS Immunol MedMicrobiol. 35, 2:131-4, 2003.

101. Reid G et al. "Probiotic Lactobacillus dose required to restore andmaintain a normal vaginal flora." FEMS Immunol Med Microbiol. 32,1:37-41, 2001.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like